Compounds > dabigatran
Page last updated: 2024-09-05

dabigatran and Lupus Erythematosus, Systemic

dabigatran has been researched along with Lupus Erythematosus, Systemic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Finsterer, J; Krutisch, G; Stöllberger, C; Wolf, HM1
Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE1
Armstrong, J; Pascu, O; Ridgley, J; Vlad, I1
Felix, SB; Greinacher, A; Hammer, F; Selleng, K; Wernicke, S1

Other Studies

4 other study(ies) available for dabigatran and Lupus Erythematosus, Systemic

ArticleYear
Dabigatran-induced lupus temporarily preventing blood group determination.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2014, Volume: 25, Issue:6

    Topics: Aged, 80 and over; Anemia; Antibodies, Antinuclear; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Group Antigens; Dabigatran; Epistaxis; Female; Humans; Immunoglobulins; Lupus Erythematosus, Systemic

2014
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

    Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Drug Substitution; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Mesenteric Veins; Middle Aged; Morpholines; Portal Vein; Recurrence; Retrospective Studies; Rivaroxaban; Splenic Vein; Stroke; Thiophenes; Thromboembolism; Thrombophilia; Treatment Failure; Venous Thrombosis; Warfarin

2014
Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.
    Clinical toxicology (Philadelphia, Pa.), 2016, Volume: 54, Issue:3

    Topics: Alcoholism; Anticoagulants; Blood Coagulation Tests; Critical Care; Dabigatran; Drug Overdose; Female; Half-Life; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Middle Aged; Monitoring, Physiologic; Pulmonary Embolism; Risk Factors; Young Adult

2016
[Recurrent thromboembolisms despite full anticoagulation in a patient with antiphospholipid syndrome].
    Der Internist, 2017, Volume: 58, Issue:7

    Topics: Anticoagulants; Antiphospholipid Syndrome; Antithrombins; Dabigatran; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Partial Thromboplastin Time; Pulmonary Embolism; Recurrence; Thromboembolism; Venous Thrombosis

2017